BofA Maintains Buy on Eli Lilly (LLY), Expects 2027 Earnings to Fully Realize Value of Obesity Drug Launches

Eli Lilly and Company (NYSE:LLY) is 1 of the best maturation stocks to bargain successful 2026. On December 15, Bank of America expert Jason Gerberry lowered the firm’s terms people connected Eli Lilly to $1,268 from $1,286 with a Buy standing connected the shares. BofA remains bullish connected Eli Lilly’s banal owed to the company’s palmy obesity merchandise launches and the dependable enlargement of its pipeline into caller therapeutic areas. 2027 projected net are expected to amended seizure the company’s semipermanent maturation potential.

In different news, connected December 12, Eli Lilly and Company announced updated results from the Phase 3 EMBER-3 survey for Inluriyo (imlunestrant), which is an oral estrogen receptor antagonist. The information highlighted the efficacy of Inluriyo some arsenic a standalone attraction and successful operation with Verzenio (abemaciclib) for patients with ER+, HER2- precocious oregon metastatic bosom crab whose illness progressed aft anterior endocrine therapy.

In patients with ESR1-mutated disease, imlunestrant monotherapy showed a clinically meaningful 38% simplification successful the hazard of progression oregon death. The operation of imlunestrant positive abemaciclib yielded adjacent much robust results crossed the broader diligent population. Safety profiles remained accordant with erstwhile reports, with nary caller signals identified during this further twelvemonth of follow-up.

Lilly has already submitted the operation information for US regulatory reappraisal successful ESR1-mutated metastatic bosom cancer. Additionally, imlunestrant is being studied successful the EMBER-4 trial, which has enrolled ~8,000 patients to analyse its imaginable successful the adjuvant mounting for aboriginal bosom cancer.

Eli Lilly and Company (NYSE:LLY) discovers, develops, and markets quality pharmaceuticals successful the US, Europe, China, Japan, and internationally.

While we admit the imaginable of LLY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.